DSM Q1 Net Sales Up 21%
DSM posted a net income of EUR130m for the first quarter 2010, or EUR0.78 per diluted share, compared to EUR13m, or EUR0.06 per diluted share, for the prior
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.
Designed by and for podiatric physicians, TRAKnet software incorporates billing, charting, scheduling, e-prescribing and inventory management to allow effortless transition from scheduling to encounters and claims while interfacing
DiabeCell is Living Cell Technologies’ treatment designed to normalise the lives of people with insulin-dependent diabetes. DiabeCell comprises encapsulated porcine insulin-producing cells (islets) that are implanted into the
The project is expected to expand Standard Process’ existing 260,000 square foot headquarters to accommodate additional processing capacity. The expansion is estimated to be completed by October 31,